Ilan Oren
Director
-
BioIlan Oren has served as Director of Roivant since 2014. He has served as Co-Chief Executive Officer of Dexcel Pharma, a privately-owned Israeli group of pharmaceutical companies, since November 2019. Ilan is currently on the board of Clexio Biosciences. Prior to serving as Co-CEO, Ilan served as Vice President for the group and led corporate and business development activities,including formation of strategic ventures, product partnerships, product portfolio selection, product acquisitions, strategic investments, and mergers and acquisitions. He holds an A.B. in Economics from Harvard College.
Ilan Oren
Director
Ilan Oren has served as a member of the Board since May, 2020. Mr. Oren also served as Co-Chief Executive Officer of Dexcel Pharma, a privately-owned Israeli group of pharmaceutical companies, since November 2019. He is currently on the board of Clexio Biosciences and Roivant Sciences. Prior to serving as Co-CEO, Mr. Oren served as Vice President for the group and led corporate and business development activities, including formation of strategic ventures, product partnerships, product portfolio selection, product acquisitions, strategic investments, and mergers and acquisitions. He holds an A.B. in Economics from Harvard College.